Moody's [MCO] vs CME [CME] Detailed Stock Comparison

Moody's Corporation

NYSE
Loading...

CME Group Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Moody's Corporation wins in 6 metrics, CME Group Inc. wins in 14 metrics, with 0 ties. CME Group Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Moody's Corporation CME Group Inc. Better
P/E Ratio (TTM) 32.74 24.34 CME Group Inc.
Price-to-Book Ratio 26.93 3.57 CME Group Inc.
Debt-to-Equity Ratio 232.68 12.86 CME Group Inc.
PEG Ratio 4.21 1.03 CME Group Inc.
EV/EBITDA 22.70 21.55 CME Group Inc.
Profit Margin (TTM) 31.69% 63.31% CME Group Inc.
Operating Margin (TTM) 45.74% 69.66% CME Group Inc.
EBITDA Margin (TTM) 45.74% 69.66% CME Group Inc.
Return on Equity 71.36% 15.92% Moody's Corporation
Return on Assets (TTM) 14.82% 1.55% Moody's Corporation
Free Cash Flow (TTM) $2.58B $4.19B CME Group Inc.
Dividend Yield 0.82% 4.11% CME Group Inc.
1-Year Return -5.09% 0.01% CME Group Inc.
Price-to-Sales Ratio (TTM) 10.12 15.36 Moody's Corporation
Enterprise Value $86.58B $103.28B CME Group Inc.
EV/Revenue Ratio 11.00 15.31 Moody's Corporation
Gross Profit Margin (TTM) 74.46% N/A N/A
Revenue per Share (TTM) $44 $19 Moody's Corporation
Earnings per Share (Diluted) $13.93 $11.73 Moody's Corporation
Beta (Stock Volatility) 1.45 0.30 CME Group Inc.
Short % of Float 2.08% 1.44% CME Group Inc.

Moody's Corporation vs CME Group Inc. Stock Performance Analysis

Loading Price Chart...

MCO
CME

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Moody's Corporation1.39%2.32%5.87%4.94%-6.86%-9.00%
CME Group Inc.-1.28%5.57%-10.97%-15.22%-2.24%-1.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Moody's Corporation-5.09%31.01%28.41%363.18%1,132.05%749.33%
CME Group Inc.0.01%46.40%27.92%186.46%384.94%196.68%

Performance & Financial Health Analysis: Moody's Corporation vs CME Group Inc.

MetricMCOCME
Market Information
Market Cap i$79.66B$103.42B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,124,9132,489,654
90 Day Avg. Volume i1,108,2612,270,221
Last Close$454.06$266.08
52 Week Range$402.28 - $546.88$244.56 - $329.16
% from 52W High-16.97%-19.16%
All-Time High$546.88 (Jan 15, 2026)$329.16 (Mar 03, 2026)
% from All-Time High-16.97%-19.16%
Growth Metrics
Quarterly Revenue Growth0.08%0.15%
Quarterly Earnings Growth0.06%0.21%
Financial Health
Profit Margin (TTM) i0.32%0.63%
Operating Margin (TTM) i0.46%0.70%
Return on Equity (TTM) i0.71%0.16%
Debt to Equity (MRQ) i232.6812.86
Cash & Liquidity
Book Value per Share (MRQ)$16.93$80.03
Cash per Share (MRQ)$8.54$7.56
Operating Cash Flow (TTM) i$3.08B$4.54B
Levered Free Cash Flow (TTM) i$2.27B$4.11B
Dividends
Last 12-Month Dividend Yield i0.82%4.11%
Last 12-Month Dividend i$3.85$12.45

Valuation & Enterprise Metrics Analysis: Moody's Corporation vs CME Group Inc.

MetricMCO (Apr 26, 2026)CME (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i32.7424.34
Forward P/E i24.5422.14
PEG Ratio i4.211.03
Price to Sales (TTM) i10.1215.36
Price to Book (MRQ) i26.933.57
Market Capitalization
Market Capitalization i$79.66B$103.42B
Enterprise Value i$86.58B$103.28B
Enterprise Value Metrics
Enterprise to Revenue i11.0015.31
Enterprise to EBITDA i22.7021.55
Risk & Other Metrics
Beta i1.450.30
Book Value per Share (MRQ) i$16.93$80.03

Financial Statements Comparison: Moody's Corporation vs CME Group Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMCO (2025)CME (2025)
Revenue/Sales i7.72B6.52B
Cost of Goods Sold i1.97B907.00M
COGS % of Revenue i25.6%13.9%
Gross Profit i5.75B5.61B
Gross Margin i74.4%86.1%
Research & Development iN/AN/A
Operating Income (EBIT) i3.46B4.23B
Operating Margin i44.9%64.9%
EBITDA i4.06B98.30M
EBITDA Margin i52.6%1.5%
Pre-Tax Income i3.13B5.33B
Pre-Tax Income % of Revenue i40.6%81.7%
Income Tax i668.00M1.26B
Income Tax % of Revenue i8.7%19.3%
Net Income (Profit) i2.46B4.07B
Profit Margin i31.9%62.5%

Balance Sheet & Liquidity Metrics

MetricMCO (2025)CME (2025)
Cash & Equivalents i2.38B4.42B
Total Current Assets iN/A165.36B
Total Current Assets % of Revenue i0.0%2,536.0%
Total Current Liabilities i2.98B160.30B
Total Current Liabilities % of Revenue i38.6%2,458.3%
Long-Term Debt i7.26B3.42B
Long-Term Debt % of Revenue i94.0%52.5%
Total Shareholders Equity i4.21B28.73B
Retained Earnings i17.85B6.43B
Retained Earnings % of Revenue i231.3%98.7%
Property, Plant & Equipment i282.00M0

Cash Flow Statement Comparison

MetricMCO (2025)CME (2025)
Operating Cash Flow i2.97B4.54B
Operating Cash Flow % of Revenue i38.4%69.6%
Capital Expenditures iN/A-83.50M
Free Cash Flow i2.58B4.19B
FCF Margin i33.4%64.3%
Debt Repayment i-700.00M-750.00M
Common Stock Repurchase i-1.71B-266.10M

Short Interest & Institutional Ownership Analysis

MetricMCOCME
Shares Short i3.18M4.70M
Short Ratio i2.252.28
Short % of Float i2.08%1.44%
Shares Outstanding i174.68M362.80M
Float Shares i163.26M357.72M
% Held by Insiders i13.99%0.48%
% Held by Institutions i79.38%91.89%
% Held by Public i6.63%7.63%

Dividend Analysis & Yield Comparison: Moody's Corporation vs CME Group Inc.

MetricMCOCME
Last 12-Month Dividend i$3.85$12.45
Last 12-Month Dividend Yield i0.82%4.11%
3-Year Avg Annual Dividend i$3.50$10.83
3-Year Avg Dividend Yield i0.20%0.92%
3-Year Total Dividends i$10.50$32.50
Ex-Dividend DateMar 02, 2026Mar 10, 2026